{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:59:04Z","timestamp":1793721544778,"version":"4.6.1"},"reference-count":165,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Spanish Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["PID2023-147401OB-I00"],"award-info":[{"award-number":["PID2023-147401OB-I00"]}]},{"name":"MICIU\/AEI"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/13543776.2025.2602702","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:42:58Z","timestamp":1765456978000},"page":"159-190","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["An updated patent review of acetylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease (2021\u2013present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Paloma","family":"Begines","sequence":"first","affiliation":[{"name":"University of Seville","place":["Seville, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 G.","family":"Fern\u00e1ndez-Bola\u00f1os","sequence":"additional","affiliation":[{"name":"University of Seville","place":["Seville, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"University of Seville","place":["Seville, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13809"},{"key":"e_1_3_6_4_1","first-page":"e105","article-title":"Dementia forecasting collaborators, estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"GBD 2019","year":"2022","unstructured":"GBD 2019. Dementia forecasting collaborators, estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet. 2022;7:e105\u2013e125.","journal-title":"Lancet"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610216000223"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101580"},{"key":"e_1_3_6_7_1","unstructured":"[cited 2025 Aug 5th]. Available from: https:\/\/www.who.int\/publications\/i\/item\/dementia-a-public-health-priority"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2013.15.4\/hjahn"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2017.02.021"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042327"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2617970"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1590\/1980-5764-dn-2021-0073"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2019.02.015"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229680800200619"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230150"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01227"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180802"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2010.03.007"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27061816"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-6-85"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1423892"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01104-7"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12683"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2021.07.014"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04220-5"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S350939"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2020.02.001"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0279-1"},{"key":"e_1_3_6_29_1","unstructured":"Alzheimer\u2019s association. [cited 2025 Aug 9th]. Available from: https:\/\/www.alz.org\/alzheimers-dementia\/treatments\/medications-for-memory"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010157"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.047"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2083956"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b14-00430"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.58347\/tml.2025.1726b"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70068"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12996-3"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01607-4"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123289"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0287-2"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00294-4"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70337"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13060"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201600161"},{"key":"e_1_3_6_44_1","first-page":"450","article-title":"Acetylcholinesterase: a versatile template to coin potent modulators of multiple therapeutic targets","volume":"57","author":"Luque FJ","year":"2024","unstructured":"Luque FJ, Mu\u00f1oz-Torrero D. Acetylcholinesterase: a versatile template to coin potent modulators of multiple therapeutic targets. Acc Chem Res. 2024;57:450\u2013467.","journal-title":"Acc Chem Res"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2010.01.042"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2024.100154"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101787"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2011.00019"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2021.1874344"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X19666201218103434"},{"key":"e_1_3_6_51_1","unstructured":"Zhang B Cui W He S et al. Preparation of 1 2 3 4-tetrahydroacridine-9-amine compound and its application in preparation of drugs. CN 112409335 A. 2021."},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105387"},{"key":"e_1_3_6_53_1","unstructured":"Yi T Huang S Luo Q et al. Preparation of tacrine-selegiline derivatives and application thereof. CN116675641 A. 2023."},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07249-6"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01760"},{"key":"e_1_3_6_56_1","unstructured":"Scheiner M Dolles D Decker M. Preparation of tacrine derivatives as cannabinoid receptor subtype 2 stimulator inhibiting acetylcholinesterase and butyrylcholinesterase. WO 2021\/018699 Al (2021)."},{"key":"e_1_3_6_57_1","unstructured":"Jiang X Liu W Liu C et al. Preparation of thiazole salt containing brain-targeted AChE inhibitor prodrug and its uses in prevention or treatment for central nervous system-Alzheimer\u2019s disease. cn 113956249 a. 2022)."},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106702"},{"key":"e_1_3_6_59_1","unstructured":"Xu J Zhang Y Gao F. Galantamine derivative for treating Alzheimer\u2019s disease and its preparation method and application. CN 116082352A. 2023."},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.2c01150"},{"key":"e_1_3_6_61_1","unstructured":"Wang H Wei L Chen H. Preparation of galantamine compounds as acetylcholinesterase inhibitors for treatment and prevention of Alzheimer\u2019s disease. CN 114621242 A. 2022."},{"key":"e_1_3_6_62_1","unstructured":"Wang Z Zeng J Lu H et al. Preparation of galantamine derivatives used for the treatment of cholinergic deficiency-related diseases. CN 118480047 A. 2024."},{"key":"e_1_3_6_63_1","unstructured":"Sun J Hao C Wang X et al. Preparation of donepezil derivative for treatment of Alzheimer\u2019s disease. CN 116478143 A. 2023."},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1RA03718H"},{"key":"e_1_3_6_65_1","unstructured":"El Mestikawy S Pietrancosta N Favier M. Synthesis of donepezil quinolinium prodrugs as acetylcholinesterase inhibitors for preventing and treating compulsive disorders and neurodegenerative disorders. 2024. WO2024161025."},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0RA09198G"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2022.104502"},{"key":"e_1_3_6_68_1","unstructured":"Yang R Lei S Wang M. Quinoline derivative containing diamine structure with good acetylcholinesterase inhibitory activity its preparation method and application. CN118026929 A. 2024."},{"key":"e_1_3_6_69_1","unstructured":"Shi Q Hou W Zou D et al. Preparation of (alkoxy)alkylquinolines as MAO-B and acetylcholinesterase inhibitors. CN 120025280 A. 2025."},{"key":"e_1_3_6_70_1","unstructured":"Singh SK Kumar A Kumar D et al. Novel quinolinyl piperazine derivatives for the treatment of Alzheimers disease. IN201911032481 A. 2021."},{"key":"e_1_3_6_71_1","unstructured":"Yang R Zhai B Hao Q et al. Preparation of quinoline derivatives as cholinesterase inhibitors. CN 119019328 A. 2024."},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107954"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115879"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117785"},{"key":"e_1_3_6_75_1","unstructured":"Wei C Liu X Nie H et al. Preparation of N-phenylquinolin-4-amine compounds as acetylcholinesterase inhibitors. CN 115466211 A. 2022."},{"key":"e_1_3_6_76_1","unstructured":"Ismaili L. Preparation of tetrahydrocarboxylates for the treatment of neurodegenerative diseases. WO 2021\/260072 Al. 2021."},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00007"},{"key":"e_1_3_6_78_1","unstructured":"Jiang Y Wu Q Yang T et al. Isoxazole formamide-4(3H)-quinazolinone derivative its synthesis method and application. CN 112898290 A. 2021."},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500130"},{"key":"e_1_3_6_80_1","unstructured":"Kaur R Singh TG Balraj S et al. Pyrazole compounds as anti-Alzheimer\u2019s agent. IN202411018323 A. 2024."},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1021\/ol026418e"},{"key":"e_1_3_6_82_1","unstructured":"Yang X Li J Cheng J et al. Preparation of indole(alkyl)piperidine compound as AChE\/SERT dual-target inhibitor for Alzheimer\u2019s disease treatment. CN 115974839 A. 2023."},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.03.040"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2281264"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep26633"},{"key":"e_1_3_6_86_1","unstructured":"Liang X Han Y Zhao Y et al. Preparation of tetrahydropyrrolizino[2 3-c]quinoline alkaloid compounds and its application. CN 119330966 A. 2025."},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.09.013"},{"key":"e_1_3_6_88_1","unstructured":"Zhao Y Luo W Mu Y et al. Preparation of benzisoquinoline-1 3(2H)-dione derivatives and its application in preparation of anti-Alzheimer\u2019s drug and fluorescence imaging reagents. CN 117551076 A. 2024."},{"key":"e_1_3_6_89_1","unstructured":"Kim SJ Narges HN. Benzothiazole-oxadiazole-acetamide for the treatment of neurodegenerative disease. KR2681130 B. 2024."},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139307"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115766"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206775193127"},{"key":"e_1_3_6_93_1","unstructured":"Sun J Pan Y Wang X et al. Preparation of 4 6-dihydroxy-2-phenylbenzofuran as AChE BChE and beta-secretase inhibitors for prevention and\/or treatment of Alzheimer\u2019s disease. CN 113336730 A. 2021."},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2021.1940993"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.35772\/ghm.2024.01033"},{"key":"e_1_3_6_96_1","first-page":"A2","article-title":"Preparation of acetylcholinesterase inhibitors for treatment of Alzheimer\u2019s disease","author":"Demirayak S","year":"2023","unstructured":"Demirayak S, Berk B, Biltekin K, et al. Preparation of acetylcholinesterase inhibitors for treatment of Alzheimer\u2019s disease. WO2023234891. 2023:A2.","journal-title":"WO2023234891"},{"key":"e_1_3_6_97_1","unstructured":"Tang W Zhang S Zhang Z et al. Preparation of cyclobutane pyridine sulfonamide compounds for Alzheimer\u2019s disease. CN 116283769 A. 2023"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115502"},{"key":"e_1_3_6_99_1","unstructured":"Wu J Ran Y Wei C et al. Preparation of (benzylpiperidinyl)alkylamides as potential multi-target anti-Alzheimer\u2019s disease agents CN 113582911 A. 2021."},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04866-w"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117178"},{"key":"e_1_3_6_102_1","unstructured":"He C Liu Q Shen J et al. Stilbene compound separated from Rheum lhasaense and application thereof in treating nervous system diseases. CN112830947 A. 2021."},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114394"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-020-01478-7"},{"key":"e_1_3_6_105_1","unstructured":"Wang Y Yu L Wang X et al. Application of flavonoid compound in preparing cholinesterase inhibitor and drug for preventing and\/or treating Alzheimer disease. CN113274383 A (2021)."},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24313-2"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2RA06961J"},{"key":"e_1_3_6_108_1","unstructured":"Sun Y Feng W Li M et al. Extraction of biflavones from Dysosna versipellis and application thereof in preparation of anti-Alzheimer\u2019s disease drug. CN 115850226 A. 2023."},{"key":"e_1_3_6_109_1","unstructured":"Sun Y Wang J Gong J et al. Xtraction of biflavone compounds from Dysosma versipellis and its application as anti-Alzheimer\u2019s disease drug. CN 115850295 A. 2023."},{"key":"e_1_3_6_110_1","unstructured":"Song S Huang X Liang J. Extraction of iridoids from the leaves of Viburnum chingii. CN115894419 a. 2023."},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2022.105400"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2024.2302318"},{"key":"e_1_3_6_113_1","unstructured":"Zhou Y Ni Z Xu Z et al. Green extraction of texasin from Caragana jubata for treatment or prevention of cerebral ischemic stroke and Alzheimer\u2019s disease. CN116283873 A. 2023."},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1487-z"},{"key":"e_1_3_6_115_1","unstructured":"Yang L Chen H Wei Y et al. Triterpene compounds with obvious inhibitory activity on acetylcholinesterase and butyrylcholinesterase preparation method and application. CN113956320 A. 2022."},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104025"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2022.113182"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bse.2024.104871"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/23802359.2023.2252944"},{"key":"e_1_3_6_120_1","unstructured":"Song S Bai M Huang X et al. Three terpenoid derivatives from Elephantopus scaber and preparation method and application thereof in drugs for preventing or treating Alzheimer\u2019s disease. CN117164660 a. 2023."},{"key":"e_1_3_6_121_1","unstructured":"Song S Huang X Yao G. Extraction of heteroterpenoids from Daphne altaica and its application in preparation of anti-Alzheimer\u2019s disease drugs. CN116789633 a. 2023."},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.109030"},{"key":"e_1_3_6_123_1","unstructured":"Lin S Shang H Wang L et al. Extraction of split-ring isoquinoline alkaloid carboxylic acid inner salt as anti-senile dementia drugs. CN114195766 A. 2022."},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115511"},{"key":"e_1_3_6_125_1","unstructured":"Liu Y Liu X Jiang K. Extraction of isoquinoline alkaloid from Fissistigma polyanthum and its application in treatment of Alzheimer\u2019s disease. CN 114805203. 2022."},{"key":"e_1_3_6_126_1","unstructured":"Song S Huang X Shuhui D et al. Extraction and purification of diarylpentane derivatives from Daphne bholua as acetylcholinesterase inhibitor. CN 115745922 A. 2023."},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c00771"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1MD00394A"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29174241"},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-023-04005-8"},{"key":"e_1_3_6_131_1","unstructured":"Wang X Ling S Peng D et al. Preparation of piperidinyl alkyoxyxanthenone compounds for treatment of Alzheimer\u2019s disease. CN 114874202. 2022."},{"key":"e_1_3_6_132_1","unstructured":"Xie S Zhang Z Liu J. Preparation of oxaanthrones as acetylcholinesterase inhibitors or drugs for Alzheimer disease. CN112552274 A. 2021."},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113154"},{"key":"e_1_3_6_134_1","unstructured":"Wu A Wu J Shen L. A method for preparing a chromone amide compound for an Alzheimer\u2032s disease drug. cn 118924749 a. 2024."},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23020250"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155972"},{"key":"e_1_3_6_137_1","unstructured":"Zhao Q Liu W Limeng W et al. Preparation of coumarin derivatives as anti-Alzheimer agents. CN115160300 A. 2022."},{"key":"e_1_3_6_138_1","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mar\u00edtin M","year":"2014","unstructured":"Llorens-Mar\u00edtin M, Jurado J, Hern\u00e1ndez F. GSK-3\u03b2, a pivotal kinase in Alzheimer disease. Front Mol Neurosci. 2014;7:46.","journal-title":"Front Mol Neurosci"},{"key":"e_1_3_6_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114689"},{"key":"e_1_3_6_140_1","unstructured":"Sun J Pan Y Wang X et al. Application and preparation method of acetylcholinesterase inhibitor in the preparation of drugs for the treatment of Alzheimer\u2019s disease. cn 113599377 a. 2021."},{"key":"e_1_3_6_141_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1NJ02950A"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24112163"},{"key":"e_1_3_6_143_1","unstructured":"Zhao Q Jiang X Li J et al. AChE\/BACE1\/GSK3\u03b2 three-target inhibitor its preparation method and application of anti-Alzheimer\u2019s disease. cn 113214282 a. 2021."},{"key":"e_1_3_6_144_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2288548"},{"key":"e_1_3_6_145_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050536"},{"key":"e_1_3_6_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116059"},{"key":"e_1_3_6_147_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00208"},{"key":"e_1_3_6_148_1","unstructured":"Xie W Hu J Chen Y. Enantioselective preparation of 3 3-disubstituted oxyindole compounds as acetylcholinesterase inhibitors for treatment of Alzheimer\u2019s disease. CN 112194609 A. 2021."},{"key":"e_1_3_6_149_1","unstructured":"Wang X Huang X Zhong L et al. Preparation of substituted isatin-ferulate derivatives and its applications. CN 118108654 A. 2024."},{"key":"e_1_3_6_150_1","unstructured":"Wang X Zhong Y Wenjia P et al. Preparation of novel substituted isatin-coumarin derivatives and its application in anti-Alzheimer agent. CN 119735585 A. 2025."},{"key":"e_1_3_6_151_1","unstructured":"Gyan PM Yash PS Gauri S et al. A natural template based anticholinestrase inhibitors and antioxidants for treatment of Alzheimer disease. IN202111016470 A. 2021."},{"key":"e_1_3_6_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116385"},{"key":"e_1_3_6_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117144"},{"key":"e_1_3_6_154_1","unstructured":"Li Z Yang L Hu P. Preparation of ethyl (S)-2-((2-(3-(2-ethoxy-2-oxoethoxy)-4-methoxyphenyl)-5-hydroxy-4-oxochroman-7-yl)oxy)acetate as a neuroprotective agent. CN 118834193 A. 2024."},{"key":"e_1_3_6_155_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0091-9"},{"key":"e_1_3_6_156_1","unstructured":"Wang G Du J Liu P et al. Preparation of 8-phenylsulfonamidyl indolo[2 1-b]quinazoline-6 12-dione derivatives and its application. CN 114874220 A. 2022."},{"key":"e_1_3_6_157_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101468"},{"key":"e_1_3_6_158_1","unstructured":"Li Z Xia J Dong S. Preparation of amide-substituted tryptanthrin derivatives as AChE inhibitors. CN 117659024 A. 2024."},{"key":"e_1_3_6_159_1","unstructured":"Li Z Xia J Wu J. Preparation of amido-substituted tryptophan ketone compounds used as acetylcholinesterase inhibitors. CN 118290425 A. 2024."},{"key":"e_1_3_6_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116013"},{"key":"e_1_3_6_161_1","unstructured":"Li Z Dong S Xia J. Preparation of deoxyvasicinone derivatives as acetylcholinesterase inhibitors. CN 117700417 A; 2024."},{"key":"e_1_3_6_162_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701323205"},{"key":"e_1_3_6_163_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019264"},{"key":"e_1_3_6_164_1","unstructured":"Du H Wang Y Mao R et al. Preparation of 9-alkyl harmine derivatives and its application as anti-Alzheimer\u2019s agent. CN 115417887 A. 2022."},{"key":"e_1_3_6_165_1","unstructured":"Gao M Zhao Q. Preparation of 1-phenyl-tetrahydro-\u03b2-carboline derivatives for treating Alzheimer\u2019s disease. CN 118344360 A. 2024."},{"key":"e_1_3_6_166_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5574207"},{"key":"e_1_3_6_167_1","unstructured":"Luo L Yang Q Wang Y. Preparation method of aminoalkoxy celastrol derivative and its application in preparation of medicine for treating and\/or preventing neurodegenerative diseases. CN 114380883 A; 2022."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2025.2602702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:33:21Z","timestamp":1770032001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2025.2602702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":165,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/13543776.2025.2602702"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2025.2602702","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}